The Italian government said it had requested clarification from American diplomats after D.H.S. said that ICE agents would help secure the U.S. Olympic delegation next week in northern Italy. By ...

Nicki Minaj made a surprise appearance at Turning Point USA’s AmericaFest on Sunday in Phoenix alongside Erika Kirk, the widow of TPUSA founder Charlie Kirk and the organization’s CEO. The pair ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

WASHINGTON—Syria has joined the U.S.-led mission to defeat Islamic State, U.S. officials said, after President Trump and Syrian President Ahmed al-Sharaa met at the White House on Monday. The move ...

Nvidia joined a $2 billion India Deep Tech Alliance as a founding member to mentor and train emerging startups. The effort expands Nvidia’s footprint in one of the world’s fastest-growing AI markets.

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...